Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bengt Glimelius

Showing results (41-50 of 431) with videos related to

Pageof 44
Sort By:
Acta Oncologica (Stockholm, Sweden)|November 3, 2018
Do we make progress in elderly patients with metastatic colorectal cancer?Bengt Glimelius, Per Pfeiffer
Acta Oncologica (Stockholm, Sweden)|August 12, 2004
Low evidence of radiation therapy in prostate cancer--a plea for intensified scientific activityBengt Glimelius, Gunnar Steineck
Acta Oncologica (Stockholm, Sweden)|March 19, 2019
Lessons learned from the maturation of a cancer drug: oxaliplatin in colorectal cancerBengt Glimelius, Peter Nygren
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2007
Proton beam therapy - do we need the randomised trials and can we do them?Bengt Glimelius, Anders Montelius
Acta Oncologica (Stockholm, Sweden)|April 28, 2017
Need for adjuvant chemotherapy after colon cancer surgery - has it decreased?Camilla Böckelman, Bengt Glimelius
Acta Oncologica (Stockholm, Sweden)|September 24, 2022
Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancerEmerik Osterlund, Bengt Glimelius
Annals of Surgical Oncology|December 30, 2019
ASO Author Reflections: Emerging Risk Factors in Colon Cancer-End of the Line for Clinomics?Erik Osterman, Bengt Glimelius
Acta Oncologica (Stockholm, Sweden)|December 22, 2007
The 'good', the 'bad', and the 'ugly' rectal cancersLennart Blomqvist, Bengt Glimelius
Acta Oncologica (Stockholm, Sweden)|October 10, 2013
What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?Gunnar Steineck, Bengt Glimelius
The Lancet. Oncology|May 9, 2014
Adjuvant chemotherapy for rectal cancerKrzysztof Bujko, Bengt Glimelius
Pageof 44

Showing results (41-50 of 431) with videos related to

Sort By:
Pageof 44
Acta Oncologica (Stockholm, Sweden)|November 3, 2018
Do we make progress in elderly patients with metastatic colorectal cancer?Bengt Glimelius, Per Pfeiffer
Acta Oncologica (Stockholm, Sweden)|August 12, 2004
Low evidence of radiation therapy in prostate cancer--a plea for intensified scientific activityBengt Glimelius, Gunnar Steineck
Acta Oncologica (Stockholm, Sweden)|March 19, 2019
Lessons learned from the maturation of a cancer drug: oxaliplatin in colorectal cancerBengt Glimelius, Peter Nygren
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2007
Proton beam therapy - do we need the randomised trials and can we do them?Bengt Glimelius, Anders Montelius
Acta Oncologica (Stockholm, Sweden)|April 28, 2017
Need for adjuvant chemotherapy after colon cancer surgery - has it decreased?Camilla Böckelman, Bengt Glimelius
Acta Oncologica (Stockholm, Sweden)|September 24, 2022
Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancerEmerik Osterlund, Bengt Glimelius
Annals of Surgical Oncology|December 30, 2019
ASO Author Reflections: Emerging Risk Factors in Colon Cancer-End of the Line for Clinomics?Erik Osterman, Bengt Glimelius
Acta Oncologica (Stockholm, Sweden)|December 22, 2007
The 'good', the 'bad', and the 'ugly' rectal cancersLennart Blomqvist, Bengt Glimelius
Acta Oncologica (Stockholm, Sweden)|October 10, 2013
What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?Gunnar Steineck, Bengt Glimelius
The Lancet. Oncology|May 9, 2014
Adjuvant chemotherapy for rectal cancerKrzysztof Bujko, Bengt Glimelius
Pageof 44